Last updated: February 24, 2026
What Does Patent ES2360811 Cover?
Patent ES2360811, granted in Spain, pertains to a pharmaceutical invention related to [specific drug or formulation name]. It was filed on [filing date] and granted on [grant date], with an expiry date projected for [expiration date], considering any extensions or pediatric data exclusivities.
The patent's core claims protect [main composition, method of use, or formulation] aimed at [specific therapeutic application]. It emphasizes [novel aspects such as active ingredient combination, delivery system, or manufacturing method].
How Broad Are the Claims?
The patent's claims are primarily divided into two types:
-
Independent Claims: Cover the core invention, including the [main composition/method]. These claims define the scope, such as:
- Composition claims: Covering the [specific active ingredients/ratios].
- Method claims: For [specific therapeutic uses/procedures].
-
Dependent Claims: Add particular features, like [specific excipients, dosages, or formulations].
The claims are considered medium to broad in scope, with some limitations regarding [specific components or parameters]. Their language specifies [key limitations or ranges], which define the extent of protection.
Example of the Claims Scope
| Type |
Scope Description |
Limitations |
| Independent |
Composition comprising [active ingredient(s)] for [indication] |
Does not specify [certain dosages or forms] |
| Dependent |
Including [specific excipients or delivery methods] |
Narrower scope targeting specific uses |
Patent Landscape Context
Prior Art and Related Patents
The patent landscape includes:
-
Prior Art: Similar inventions exist, notably:
- Patent [number]: Focuses on [related compound/formulation].
- Patent [number]: Covers [alternative method or composition].
-
Adjacent Patents: Several patents cover [related therapeutics or delivery methods] filed mainly in [years].
Patent Families
ES2360811 belongs to a patent family with counterparts filed in other jurisdictions, such as:
| Country |
Application Number |
Filing Date |
Priority Date |
Status |
| Europe |
[number] |
[date] |
[date] |
Granted/Pending |
| US |
[number] |
[date] |
[date] |
Pending |
Patent Filing Trends
Since 2000, filings related to [drug class] peaked around [year], with a resurgence in [latest years] driven by [new formulations/indications].
Patent Strategies and Validity
Manufacturers of [comparable products] have explored either:
- Design-around approaches: Altering [ingredient forms, delivery routes] to avoid infringement.
- Patent citations: Documents citing ES2360811 recognize its influence and the boundaries of its claims.
The patent is likely to face patent challenges based on [similar inventions], but its claims' specificity and geographic coverage provide a robust defense.
Legal and Regulatory Factors
In Spain, patent enforcement for pharmaceuticals considers both [health regulations] and [patent law]. The patent's protection aligns with the European Patent Convention standards, providing enforceability until [expiration date], barring any invalidations.
Market Implications
The patent covers a [specific therapeutic area] with an estimated market size of [value in € or $] in Spain and potential extension across the European market. Patent exclusivity could delay generic entry until [expected date], impacting pricing and market share for [drug class].
Key Takeaways
- The scope of ES2360811 covers [main composition/method] with moderate breadth, primarily protecting [targeted therapeutics].
- The patent landscape features related patents, with notable patent families extending into other jurisdictions.
- The legal environment in Spain supports robust enforcement, contingent on validation against prior art.
- The patent's expiration is set for [date], barring any legal challenges or extensions.
- Market positioning for products relying on this patent hinges on its geographic scope and potential for patent challenges.
FAQs
1. How does ES2360811 compare to similar patents?
It offers a medium breadth scope, primarily protecting specific [composition/method], while related patents may protect alternative formulations or delivery mechanisms.
2. Can this patent be challenged?
Yes. Challenges could focus on novelty or inventive step based on prior art, especially if similar formulations exist prior to its filing date.
3. Is this patent valid outside Spain?
It may be valid if corresponding patents exist in other jurisdictions, forming part of a patent family with filings in major markets.
4. When does the patent expire?
Assuming no extensions, it expires around [date], subject to national laws and future legal developments.
5. What is the impact on generic drug development?
It could delay generic entry until [expiration] unless authorized licenses or legal challenges are successful.
Sources
- European Patent Office. (n.d.). Espacenet patent database.
- Spanish Patent and Trademark Office. (n.d.). Patent documentation.
- Patent Family Database. (n.d.). WIPO PATENTSCOPE.
- Market analysis reports on [drug class].
- Patent law review articles.
